Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Nanotech Treatment Studied for Brain Tumors

Medical researchers and engineers designed and tested in mice a way to deliver gene-silencing therapies in nanoscale particles to treat glioblastoma, an aggressive form of brain cancer. . . . → Read More: Nanotech Treatment Studied for Brain Tumors

Lab-On-Chip Quickly Isolates, Captures Exosomes

Tests of a lab-on-a-chip system show the device can rapidly isolate and recover cellular carriers of biomarkers useful in detecting cancer and other diseases. . . . → Read More: Lab-On-Chip Quickly Isolates, Captures Exosomes

Feasibility, Safety Shown for Personal Tumor Vaccine

A pilot study among individuals with a form of skin cancer shows a vaccine aiming at proteins specific to a person’s tumor is safe and can generate a complex immune response attacking the tumor. . . . → Read More: Feasibility, Safety Shown for Personal Tumor Vaccine

NIH Funds Nanotech Tools for Cancer, Blood Clots

A bioengineering lab is receiving awards from National Institutes of Health to apply nanotechnology to treatments for breast cancer and diagnostics for deep vein blood clots. . . . → Read More: NIH Funds Nanotech Tools for Cancer, Blood Clots

Second Trial Approved for Cancer Pain Drug

The U.S. Food and Drug Administration approved a new clinical trial to test the efficacy and safety of an experimental drug designed to relieve stubborn chronic pain associated with cancer. . . . → Read More: Second Trial Approved for Cancer Pain Drug

Cancer Drug Produced in Small Continuous-Flow Batches

A team from drug maker Eli Lilly & Company devised techniques for producing an experimental cancer drug in small quantities but with safe, economical methods used in continuous flow manufacturing. . . . → Read More: Cancer Drug Produced in Small Continuous-Flow Batches

Supreme Court Cuts Biosimilar Waiting Time

The U.S. Supreme Court ruled yesterday that makers of biologic drugs similar to branded originals need not wait an additional 6 months to begin marketing their products. . . . → Read More: Supreme Court Cuts Biosimilar Waiting Time

Cancer Center to Test Focused Radiation Therapy

MD Anderson Cancer Center is testing new radiation treatments for cancer designed to reduce adverse side effects of conventional radiation therapy. . . . → Read More: Cancer Center to Test Focused Radiation Therapy

Symptom Alerts Linked to Longer Cancer Survival

A clinical trial shows cancer patients using an online system to report their symptoms have somewhat longer survival times than patients not using this service. . . . → Read More: Symptom Alerts Linked to Longer Cancer Survival

Engineered Immune Cells to be Explored for Solid Tumors

A cancer research center and biotechnology company will examine genetically engineered immune system cells as possible treatments for solid tumor cancers. . . . → Read More: Engineered Immune Cells to be Explored for Solid Tumors